Table 3.

The Genotypic Frequency of Polymorphisms Between T2DM and Control Groups

SNP		Control n (%)	T2DM n (%)	p-value
rs1470579 IGF2BP2	AA	55 (51.89%)	67 (41.36%)	0.001*
	CC	11 (10.38%)	55 (33.95%)
	AC	40 (37.74%)	40 (24.69%)
rs2237892 KCNQ1	TT	6 (5.66%)	1 (0.62%)	0.002*
	CC	85 (80.19%)	152 (93.83%)
	CT	15 (14.15%)	9 (5.56%)
rs7903146 TCF7L2	CC	51 (48.11%)	26 (16.05%)	0.001*
	CT	39 (36.79%)	76 (46.91%)
	TT	16 (15.09%)	60 (37.04%)
rs8050136 FTO	CC	25 (23.58%)	42 (25.93%)	0.132
	AA	60 (56.60%)	73 (45.06%)
	AC	21 (19.81%)	47 (29.01%)
rs10830963 MTNR1B	CC	52 (49.06%)	58 (35.80%)	0.079
	CG	44 (41.51%)	80 (49.38%)
	GG	10 (9.43%)	24 (14.81%)
rs10946398 CDKAL1	AA	46 (43.40%)	31 (19.14%)	0.001*
	CC	10 (9.43%)	27 (16.67%)
	AC	50 (47.17%)	104 (64.20%)
rs13266634SLC30A8	TT	78 (73.58%)	82 (50.62%)	0.001*
	CC	5 (4.72%)	16 (9.88%)
	CT	23 (21.70%)	64 (39.51%)

Note: *statistically significant.